FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Invention discloses a carbohydrate-binding protein C1q-domain-containing protein from the marine bivalve mollusk Modiolus kurilensis (MkC1qDC) with the amino acid sequence SEQ ID NO.1 and a method for isolation thereof. Hemolymph is obtained from sea bivalve mollusk Modiolus kurilensis. Plasma is separated from cell fraction. Enriched fraction is obtained from cell-free hemolymph by salting out with ammonium sulphate. Obtained fraction has the highest hemagglutinating activity, which is effectively inhibited by acidic derivatives of galactose and mannose, including their oligomeric and polymer forms. Purified carbohydrate-recognizing protein MkC1qDC is then recovered by affinity chromatography with immobilized glycans containing acidic derivatives of galactose or mannose.
EFFECT: carbohydrate-binding protein MkC1qDC from Modiolus kurilensis bivalve exhibits antibacterial properties with respect to gram-positive and gram-negative microorganisms.
2 cl, 4 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ASSESSMENT OF HEALTH OF MARINE BIVALVED MOLLUSCS AND CONDITION OF THEIR HABITAT | 2014 |
|
RU2571817C1 |
HUMAN RECOMBINANT MANNAN-BINDING LECTIN | 2000 |
|
RU2292217C2 |
POLYSACCHARIDE AND ITS DERIVATIVES WITH ACTIVITY TO FICOLIN-3, METHOD FOR OBTAINING AND APPLICATION THEREOF | 2011 |
|
RU2575752C2 |
METHOD FOR DETERMINING ACTIVITY OF MANNAN-BINDING LECTIN-ASSOCIATED SERINE PROTEASES IN A FIBRINOGEN COAGULATION TEST | 2019 |
|
RU2739113C1 |
LECTIN FROM ROBINIA PSEUDOACACIA AND ITS APPLICATION | 1998 |
|
RU2214259C2 |
METHOD FOR OBTAINING A VEGETABLE ML1 LECTURE FROM A MISSILE WHITE AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS (VARIANTS) | 2016 |
|
RU2644332C1 |
RECOMBINANT LECTIN FROM WHITE MISTLETOE (RML) | 1996 |
|
RU2241750C2 |
EXPRESSING CONSTRUCTION, EXPRESSING VECTOR PEDII CS150 AND METHOD FOR PRODUCING RECOMBINANT POLYPEPTIDE | 1999 |
|
RU2241035C2 |
METHOD OF PRODUCING AND DETERMINING SPECIFIC ACTIVITY OF MACROPHAGE ACTIVATION FACTOR GcMAF | 2023 |
|
RU2823530C1 |
DETERMINING THE ACTIVITY OF THE CLASSICAL PATHWAY OF THE COMPLEMENT SYSTEM IN A FIBRINOGEN COAGULATION TEST | 2019 |
|
RU2707568C1 |
Authors
Dates
2024-09-23—Published
2021-12-30—Filed